Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.500 CHF | +7.07% |
|
+12.70% | -62.46% |
Jul. 11 | DOCMORRIS : Receives a Buy rating from Jefferies | ZD |
Jul. 03 | DOCMORRIS : Deutsche Bank reaffirms its Neutral rating | ZD |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -7.01 | -9.51 | -7.94 | -5.16 | -7.84 | |||||
Return on Total Capital | -8.71 | -11.72 | -9.95 | -6.19 | -9.12 | |||||
Return On Equity % | -28.94 | -44.41 | -40.95 | -30.09 | -25.24 | |||||
Return on Common Equity | -28.95 | -44.41 | -40.95 | -30.09 | -25.24 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 16.34 | 15.06 | 15.27 | 20.98 | 21.29 | |||||
SG&A Margin | 10.01 | 8.88 | 10.1 | 11.72 | 10.23 | |||||
EBITDA Margin % | -7.75 | -10.29 | -8.23 | -6.73 | -8.72 | |||||
EBITA Margin % | -8.2 | -10.75 | -8.87 | -7.65 | -9.47 | |||||
EBIT Margin % | -8.61 | -11.23 | -9.35 | -8.37 | -10.14 | |||||
Income From Continuing Operations Margin % | -9.18 | -13.07 | -10.64 | -12.13 | -9.56 | |||||
Net Income Margin % | -9.19 | -13.07 | -10.64 | 8.49 | -9.56 | |||||
Net Avail. For Common Margin % | -9.19 | -13.07 | -10.64 | -12.13 | -9.56 | |||||
Normalized Net Income Margin | -6.04 | -8.11 | -7.04 | -7.93 | -7.16 | |||||
Levered Free Cash Flow Margin | -10.57 | -5.75 | -5.41 | -11.65 | 4.07 | |||||
Unlevered Free Cash Flow Margin | -9.95 | -5.16 | -4.72 | -10.41 | 5.27 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.3 | 1.36 | 1.36 | 0.99 | 1.24 | |||||
Fixed Assets Turnover | 17 | 17.68 | 16.45 | 12.21 | 18.06 | |||||
Receivables Turnover (Average Receivables) | 12.18 | 13.93 | 12.26 | 10.5 | 18.59 | |||||
Inventory Turnover (Average Inventory) | 15.11 | 15.82 | 15.52 | 11.36 | 18.02 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.44 | 2.53 | 1.64 | 1.63 | 1.83 | |||||
Quick Ratio | 2.75 | 1.97 | 1.22 | 1.01 | 1.48 | |||||
Operating Cash Flow to Current Liabilities | -0.43 | -0.61 | -0.4 | -0.48 | -0.23 | |||||
Days Sales Outstanding (Average Receivables) | 30.05 | 26.19 | 29.77 | 34.78 | 19.68 | |||||
Days Outstanding Inventory (Average Inventory) | 24.22 | 23.07 | 23.52 | 32.14 | 20.31 | |||||
Average Days Payable Outstanding | 27.9 | 29.15 | 34.45 | 38.88 | 22.83 | |||||
Cash Conversion Cycle (Average Days) | 26.37 | 20.11 | 18.85 | 28.04 | 17.16 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 99.03 | 108.3 | 150.7 | 76.84 | 91.8 | |||||
Total Debt / Total Capital | 49.76 | 51.99 | 60.11 | 43.45 | 47.86 | |||||
LT Debt/Equity | 97.81 | 107.23 | 140.58 | 54.88 | 90.54 | |||||
Long-Term Debt / Total Capital | 49.14 | 51.48 | 56.07 | 31.03 | 47.21 | |||||
Total Liabilities / Total Assets | 58.41 | 61.79 | 68.09 | 50.31 | 56.29 | |||||
EBIT / Interest Expense | -8.64 | -11.98 | -8.49 | -4.24 | -5.28 | |||||
EBITDA / Interest Expense | -7.35 | -10.58 | -7.14 | -3.13 | -4.28 | |||||
(EBITDA - Capex) / Interest Expense | -9.15 | -11.49 | -8.01 | -3.39 | -4.35 | |||||
Total Debt / EBITDA | -4.86 | -3.07 | -4.18 | -5.52 | -3.73 | |||||
Net Debt / EBITDA | -2.08 | -1.44 | -2.94 | -3.79 | -2.59 | |||||
Total Debt / (EBITDA - Capex) | -3.91 | -2.82 | -3.72 | -5.1 | -3.67 | |||||
Net Debt / (EBITDA - Capex) | -1.67 | -1.33 | -2.62 | -3.49 | -2.55 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.96 | 16.9 | -6.85 | 4.13 | 4.91 | |||||
Gross Profit, 1 Yr. Growth % | 15.66 | 7.75 | -5.54 | 26.97 | 6.49 | |||||
EBITDA, 1 Yr. Growth % | 61.15 | 54.12 | -25.56 | -51.67 | 35.92 | |||||
EBITA, 1 Yr. Growth % | 59.07 | 52.21 | -23.2 | -47.98 | 29.81 | |||||
EBIT, 1 Yr. Growth % | 56.66 | 51.43 | -22.53 | -45.97 | 26.98 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 158.98 | 66.42 | -24.2 | -31.29 | -17.28 | |||||
Net Income, 1 Yr. Growth % | 159.17 | 66.35 | -24.2 | -148.08 | -218.2 | |||||
Normalized Net Income, 1 Yr. Growth % | 66.93 | 55.89 | -19.2 | -31.84 | -5.32 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 147.41 | 56.54 | -32.14 | -36.58 | -18.08 | |||||
Accounts Receivable, 1 Yr. Growth % | -9.26 | 14.79 | -1.87 | -57.18 | -2.5 | |||||
Inventory, 1 Yr. Growth % | 31.63 | -0.51 | -10.04 | -37.78 | -28.37 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 25.22 | 2.2 | -1.92 | -35.9 | -18.46 | |||||
Total Assets, 1 Yr. Growth % | 28.91 | -0.72 | -13.38 | -21.19 | -10.19 | |||||
Tangible Book Value, 1 Yr. Growth % | 22.14 | 51.71 | 100.23 | -70.81 | 139.26 | |||||
Common Equity, 1 Yr. Growth % | 31.08 | -8.8 | -27.66 | 22.74 | -21 | |||||
Cash From Operations, 1 Yr. Growth % | -18.24 | 93.5 | -25.53 | -10.15 | -69.57 | |||||
Capital Expenditures, 1 Yr. Growth % | 154.16 | -44.65 | 5.8 | -61.35 | -72.71 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 787.6 | -36.68 | -12.4 | 25.16 | -135.52 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 928.27 | -39.58 | -14.88 | 27.38 | -151.26 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.61 | 12.86 | 4.35 | -25.07 | 4.52 | |||||
Gross Profit, 2 Yr. CAGR % | 12.34 | 11.64 | 0.89 | -11.57 | 16.28 | |||||
EBITDA, 2 Yr. CAGR % | 115.65 | 58.15 | 7.2 | -39.44 | -18.95 | |||||
EBITA, 2 Yr. CAGR % | 102.51 | 56.12 | 8.21 | -36.81 | -17.82 | |||||
EBIT, 2 Yr. CAGR % | 103.02 | 54.51 | 8.4 | -35.34 | -17.17 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 86.26 | 107.6 | 12.32 | -27.83 | -24.61 | |||||
Net Income, 2 Yr. CAGR % | 86.6 | 107.64 | 12.3 | -39.63 | -24.61 | |||||
Normalized Net Income, 2 Yr. CAGR % | 98.76 | 61.78 | 12.31 | -25.92 | -19.67 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 56.04 | 96.8 | 3.06 | -34.4 | -27.92 | |||||
Accounts Receivable, 2 Yr. CAGR % | 9.49 | 2.06 | 6.13 | -35.33 | -35.39 | |||||
Inventory, 2 Yr. CAGR % | 15.72 | 14.44 | -5.4 | -25.18 | -33.24 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 67.82 | 13.13 | 0.12 | -20.71 | -27.7 | |||||
Total Assets, 2 Yr. CAGR % | 32.66 | 13.13 | -7.27 | -17.38 | -15.87 | |||||
Tangible Book Value, 2 Yr. CAGR % | -36.22 | 36.12 | 74.29 | -23.55 | -16.43 | |||||
Common Equity, 2 Yr. CAGR % | 9.49 | 9.34 | -18.78 | -5.78 | -1.53 | |||||
Cash From Operations, 2 Yr. CAGR % | 42.54 | 25.78 | 20.04 | -18.2 | -47.71 | |||||
Capital Expenditures, 2 Yr. CAGR % | 60.48 | 18.6 | -23.48 | -41.59 | -67.53 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 74.66 | 137.46 | -25.45 | 6.59 | -32.26 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 71.21 | 149.68 | -28.21 | 6.34 | -17.75 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 14.25 | 12.67 | 5.86 | -13.09 | -16.17 | |||||
Gross Profit, 3 Yr. CAGR % | 16.13 | 10.79 | 5.59 | -5.55 | -5.92 | |||||
EBITDA, 3 Yr. CAGR % | 57.73 | 93.26 | 23.09 | -17.27 | -20.71 | |||||
EBITA, 3 Yr. CAGR % | 54.22 | 84.53 | 23.31 | -15.25 | -19.67 | |||||
EBIT, 3 Yr. CAGR % | 56.33 | 84.51 | 22.82 | -14.09 | -19.03 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 55.23 | 79.39 | 48.38 | -4.66 | -24.47 | |||||
Net Income, 3 Yr. CAGR % | 55.29 | 79.59 | 48.4 | -15.36 | -24.47 | |||||
Normalized Net Income, 3 Yr. CAGR % | 65.42 | 83.65 | 28.41 | -5.02 | -19.61 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 29.12 | 56.21 | 38 | -12.34 | -29.36 | |||||
Accounts Receivable, 3 Yr. CAGR % | 9.15 | 11.23 | 0.73 | -21.7 | -25.84 | |||||
Inventory, 3 Yr. CAGR % | 16.17 | 10.04 | 5.61 | -17.73 | -26.26 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 48.18 | 42.25 | 7.87 | -13.71 | -19.97 | |||||
Total Assets, 3 Yr. CAGR % | 40.42 | 20.44 | 3.5 | -12.16 | -15.05 | |||||
Tangible Book Value, 3 Yr. CAGR % | -20.78 | -14.86 | 54.81 | -3.93 | 11.83 | |||||
Common Equity, 3 Yr. CAGR % | 21.84 | 3.02 | -4.73 | -6.8 | -11.15 | |||||
Cash From Operations, 3 Yr. CAGR % | 44.82 | 57.83 | 5.62 | 8.99 | -41.17 | |||||
Capital Expenditures, 3 Yr. CAGR % | 73.22 | 12.54 | 14.17 | -42.63 | -54.68 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 73.57 | 24.68 | 70.42 | -10.34 | -25.32 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 72.9 | 21.13 | 74.55 | -11.86 | -15.63 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.99 | 14.33 | 10.18 | -4.29 | -5.58 | |||||
Gross Profit, 5 Yr. CAGR % | 13.22 | 13.8 | 9.77 | 1.24 | 0.75 | |||||
EBITDA, 5 Yr. CAGR % | 65.29 | 120.24 | 35.35 | 21.54 | 4.55 | |||||
EBITA, 5 Yr. CAGR % | 77.13 | 94.44 | 34.02 | 20.24 | 4.82 | |||||
EBIT, 5 Yr. CAGR % | 80.82 | 93.81 | 35.2 | 21.34 | 4.89 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 108.47 | 77.62 | 36.38 | 24.63 | 13.18 | |||||
Net Income, 5 Yr. CAGR % | 108.49 | 77.62 | 36.4 | 16.12 | 13.18 | |||||
Normalized Net Income, 5 Yr. CAGR % | 104 | 77.48 | 41.85 | 27.76 | 6.37 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 69.45 | 45.41 | 17.99 | 10.4 | 6.42 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.08 | 12.81 | 7.93 | -10.46 | -15.74 | |||||
Inventory, 5 Yr. CAGR % | 21.73 | 13.88 | 7.01 | -5.7 | -12.09 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 29.82 | 30.36 | 26.67 | 12.59 | -8.08 | |||||
Total Assets, 5 Yr. CAGR % | 40.51 | 37.15 | 18.95 | 3.58 | -4.74 | |||||
Tangible Book Value, 5 Yr. CAGR % | 30.74 | 22.11 | 8.59 | -18.45 | 20.98 | |||||
Common Equity, 5 Yr. CAGR % | 48.85 | 36.11 | 3.59 | -0.6 | -3.46 | |||||
Cash From Operations, 5 Yr. CAGR % | 29.04 | 56.69 | 34.35 | 21.34 | -20.27 | |||||
Capital Expenditures, 5 Yr. CAGR % | 34.89 | 37.11 | 24.93 | -13.43 | -33.41 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 89.79 | 24.98 | 23.87 | 17.14 | 18.67 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 79.51 | 23.52 | 21.73 | 15.03 | 30.27 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | - |
- Stock Market
- Equities
- ROSE Stock
- Financials DocMorris AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions